Online Program

Return to main conference page

All Times EDT

Friday, September 24
Fri, Sep 24, 2:15 PM - 3:30 PM
Virtual
Tools to Enable the Use of R by the Biopharmaceutical Industry in a Regulatory Setting

R for Regulatory Submissions: Challenges and Approaches (302474)

*Paul Schuette, US Food and Drug Administration 

Keywords: R, Statistical Software, Regulatory Submissions

As stated in FDA’s 2015 Statistical Software Clarifying Statement, FDA does not require the use a specific statistical software package for regulatory submissions. This talk will address some of the challenges and potential solutions for using R in regulatory submissions. Additionally, we shall briefly discuss initiatives to support R submissions such as those of the R Validation Hub, R Consortium efforts and TransCelerate’s recommendations for “Modernization of Statistical Analytics.”